Galectin Therapeutics (GALT) volatility elevated on sharp rally

September 20, 2016 12:58 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Galectin Therapeutics (NASDAQ: GALT) up 11%. 30-day call option implied volatility of 156 compares to volatility of 107 from a month ago.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Options, Trader Talk

Related Entities


Add Your Comment